| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |